Following the FDA’s Oral Cleft Warning

 

Following the FDA’s Oral Cleft Warning on Topamax, CJF Launched an Educational 
The Open Press (press release)
According to this recent FDA action, there is an increased risk of oral clefts like cleft lip and cleft palateamong infants whose mothers take Topamax while pregnant (fda.gov). After reviewing new Topamax birth defect data, the FDA has also elevated 

 
 
 

Comments are closed.